This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2011 Apr 1;4(2):195-205.

doi: 10.1161/CIRCINTERVENTIONS.110.959882.

Restenosis: delineating the numerous causes of drug-eluting stent restenosis

Vasim Farooq¹, Bill D Gogas, Patrick W Serruys

Affiliations

PMID: 21505166
DOI: 10.1161/CIRCINTERVENTIONS.110.959882

Review

Restenosis: delineating the numerous causes of drug-eluting stent restenosis

Vasim Farooq et al. Circ Cardiovasc Interv. 2011.

. 2011 Apr 1;4(2):195-205.

doi: 10.1161/CIRCINTERVENTIONS.110.959882.

Authors

Vasim Farooq¹, Bill D Gogas, Patrick W Serruys

Affiliation

¹ Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.

PMID: 21505166
DOI: 10.1161/CIRCINTERVENTIONS.110.959882

No abstract available

PubMed Disclaimer

Similar articles

Inflammation inhibitory effects of sirolimus and paclitaxel-eluting stents on interleukin-1β-induced coronary artery in-stent restenosis in pigs.
Zhou XC, Huang RC, Zhang B, Yin D, Liang B, Wang SP, Guan QG, Sun XZ, Miao ZL, He XZ, Han FT, Cheng Y, Zhang L, Zeng DY. Zhou XC, et al. Chin Med J (Engl). 2010 Sep;123(17):2405-9. Chin Med J (Engl). 2010. PMID: 21034557
Atypical "black hole" phenomenon after treatment of sirolimus stent restenosis with a paclitaxel-coated balloon.
Linares Vicente JA, Lukic A, Gonzalo López N, Ruiz Arroyo JR. Linares Vicente JA, et al. EuroIntervention. 2012 Apr;7(12):1479. doi: 10.4244/EIJV7I12A231. EuroIntervention. 2012. PMID: 22522559 No abstract available.
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
Park DW, Kim YH, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Seong IW, Lee JH, Tahk SJ, Jeong MH, Jang Y, Cheong SS, Yang JY, Lim DS, Seung KB, Chae JK, Hur SH, Lee SG, Yoon J, Lee NH, Choi YJ, Kim HS, Kim KS, Kim HS, Hong TJ, Park HS, Park SJ. Park DW, et al. J Am Coll Cardiol. 2010 Oct 5;56(15):1187-95. doi: 10.1016/j.jacc.2010.03.086. J Am Coll Cardiol. 2010. PMID: 20883925 Clinical Trial.
Drug-eluting stents.
García-García HM, Vaina S, Tsuchida K, Serruys PW. García-García HM, et al. Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Arch Cardiol Mex. 2006. PMID: 17091802 Review.
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K. Doostzadeh J, et al. Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Coron Artery Dis. 2010. PMID: 19952925 Review.

See all similar articles

Cited by

Myocardial Work Evaluation-A Useful Non-Invasive Method to Predict Coronary Artery Sub-Occlusion in a Patient with Unstable Angina and Multiple Myocardial Revascularization Interventions.
Gheorghiu A, Arnautu SF, Slovenski M, Malița CD, Tomescu MC, Arnautu DA. Gheorghiu A, et al. Diagnostics (Basel). 2023 Apr 18;13(8):1459. doi: 10.3390/diagnostics13081459. Diagnostics (Basel). 2023. PMID: 37189560 Free PMC article.
Quantifying lumen diameter in coronary artery stents with high-resolution photon counting detector CT and convolutional neural network denoising.
Koons EK, Thorne JE, Huber NR, Chang S, Rajendran K, McCollough CH, Leng S. Koons EK, et al. Med Phys. 2023 Jul;50(7):4173-4181. doi: 10.1002/mp.16415. Epub 2023 Apr 17. Med Phys. 2023. PMID: 37069830
Novel application of drug-coated balloons in coronary heart disease: A narrative review.
Wang L, Li X, Li T, Liu L, Wang H, Wang C. Wang L, et al. Front Cardiovasc Med. 2023 Mar 2;10:1055274. doi: 10.3389/fcvm.2023.1055274. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36937937 Free PMC article. Review.
The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention.
Giantini A, Timan IS, Dharma R, Sukmawan R, Setiabudy R, Alwi I, Harahap AR, Listiyaningsih E, Partakusuma LG, Tansir AR, Sahar W, Hidayat R. Giantini A, et al. Front Cardiovasc Med. 2023 Feb 8;9:1027892. doi: 10.3389/fcvm.2022.1027892. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36843628 Free PMC article.
Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.
Donisan T, Madanat L, Balanescu DV, Mertens A, Dixon S. Donisan T, et al. Curr Cardiol Rev. 2023;19(3):e030123212355. doi: 10.2174/1573403X19666230103154638. Curr Cardiol Rev. 2023. PMID: 36597603 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.